Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Klotho Neurosciences ( (KLTO) ).
On June 9, 2025, Klotho Neurosciences entered into a Stock Purchase Agreement to sell shares of its Series B Preferred stock for $500,000. These shares can be converted into common stock following SEC approval. The transaction was exempt from registration under the Securities Act of 1933, relying on a pre-existing relationship with the purchaser, who was deemed knowledgeable and capable of evaluating the investment risks. The sale was completed without underwriters or sales commissions.
More about Klotho Neurosciences
Average Trading Volume: 37,250,813
Technical Sentiment Signal: Hold
Current Market Cap: $47.12M
See more insights into KLTO stock on TipRanks’ Stock Analysis page.